ISSN 2149-3235 | E-ISSN 2149-3057
RELATED ARTICLES
Editorial
An unusual foreign body in the urinary bladder: beading awl
(Turk J Urol 2011; 37: 275-277)
Evaluation of information about urologic disorders on the Internet: a pilot study of varicoceles
(Turk J Urol 2011; 37: 321-325)
DOI: 10.5152/tud.2011.053
Placenta percreta with bladder invasion: a rare cause of hematuria in pregnancy
(Turk J Urol 2011; 37: 372-374)
DOI: 10.5152/tud.2011.072
Anterior sacral meningocele mimicking bladder neck rupture on ultrasonography
(Turk J Urol 2011; 37: 375-377)
DOI: 10.5152/tud.2011.073
Case Report
Transvaginal repair of unrecognized bladder injury after transobturator tape surgery
(Turk J Urol 2013; 39: 277-280)
DOI: 10.5152/tud.2013.067
Giant vesical diverticulum, unilateral renal agenesis and mental retardation: an unusual association
(Turk J Urol 2012; 38: 112-113)
DOI: 10.5152/tud.2012.024
Urinary bladder carcinosarcoma: a complete pathological response after neoadjuvant chemotherapy
(Turk J Urol 2012; 38: 114-116)
DOI: 10.5152/tud.2012.024
Secondary nonmonosymptomatic enuresis diurna as the first manifestation of transitional cell papillary carcinoma of the bladder in a 14-year-old girl
(Turk J Urol 2012; 38: 170-172)
DOI: 10.5152/tud.2012.036
Primary amyloidosis of the bladder mimicking bladder tumor
(Turk J Urol 2014; 40: 59-61)
DOI: 10.5152/tud.2014.65632
INFLAMMATUAR PSEUDOTUMOR OF THE BLADDER: REPORT OF 2 CASES AND LITERATURE REVIEW
(Turk J Urol 2005; 31: 274-277)
Carcinosarcoma/sarcomatoid carcinoma of the urinary bladder with features of malignant fibrous histiocytoma: the role of p53 in growth of the tumor
(Turk J Urol 2011; 37: 172-176)
SMALL CELL CARCINOMA OF BLADDER: A CASE REPORT
(Turk J Urol 2005; 31: 596-598)
An unusual natural history of a rare bladder tumor: Primitive neuroectodermal tumor
(Turk J Urol ; : -)
DOI: 10.5152/tud.2018.59752
Hamartoma of the urinary bladder in a 15-year-old boy
(Turk J Urol 2016; 42: 101-103)
DOI: 10.5152/tud.2016.45077
Unusual foreign body in the vesico-urethral; 195 cm liquid pipe
(Turk J Urol 2014; 40: 248-250)
DOI: 10.5152/tud.2014.06881
Granulomatous prostatitis diagnosed during intravesical BCG treatment
(Turk J Urol 2013; 39: 204-206)
DOI: 10.5152/tud.2013.042
Recurrence of childhood nephrogenic adenoma in urinary bladder developed four years after previous surgery despite intravesical sodium hyaluronate therapy
(Turk J Urol 2016; 42: 303-306)
DOI: 10.5152/tud.2016.84579
Management of a patient with vesicocutaneous fistula presenting 13 years after radiotherapy performed for cervical cancer
(Turk J Urol 2018; 44: 185-188)
DOI: 10.5152/tud.2017.35929
Urothelial carcinoma of the allograft kidney developed in a renal transplant patient
(Turk J Urol 2016; 42: 213-215)
DOI: 10.5152/tud.2016.97415
Transitional cell carcinoma of the urinary bladder with skeletal muscle metastasis: a case report and review of the literature
(Turk J Urol 2009; 35: 378-383)
Granular cell tumor of the urinary bladder
(Turk J Urol 2017; 43: 383-385)
DOI: 10.5152/tud.2017.44538
Review
General evaluation of neurogenic bladder in children
(Turk J Urol 2010; 36: 160-166)
Bladder cancer and eosinophilic cystitis
(Turk J Urol 2010; 36: 339-343)
Small cell carcinoma of the genitourinary system
(Turk J Urol 2010; 36: 344-349)
Medical management of benign prostatic hyperplasia in the light of available evidence
(Turk J Urol 2010; 36: 418-429)
Management of bladder transitional cell carcinoma in stage T1G3
(Turk J Urol 2010; 36: 119-124)
MANAGEMENT OF BCG-REFRACTORY SUPERFICIAL BLADDER CANCER
(Turk J Urol 2005; 31: 465-468)
What are the currently available and in development molecular markers for bladder cancer? Will they prove to be useful in the future?
(Turk J Urol 2014; 40: 228-232)
DOI: 10.5152/tud.2014.60973
Original Article
Role of percutaneous posterior tibial nerve stimulation either alone or combined with an anticholinergic agent in treating patients with overactive bladder
(Turk J Urol 2015; 41: 208-214)
DOI: 10.5152/tud.2015.94210
The effects of etiological factors on the results of augmentation enterocystoplasty: spinal cord injuries versus chronic tuberculosis cystitis
(Turk J Urol 2012; 38: 154-158)
DOI: 10.5152/tud.2012.033
The relationship of the lymph node positivity to the durations between the initial and last TUR-T and radical cystectomy, and the number of TUR-T in invasive bladder tumors
(Turk J Urol 2010; 36: 13-17)
Comparison of the radical cystectomy and bladder-sparing treatments in terms of survival and quality of life in bladder cancer treatment: a retrospective study
(Turk J Urol 2010; 36: 18-24)
Blunt and penetrating bladder injuries
(Turk J Urol 2010; 36: 76-80)
The relationship between microscopic hematuria and bladder cancer: are currently available diagnostic methods reliable?
(Turk J Urol 2010; 36: 103-107)
Comparison of bipolar plasmakinetic energy and conventional techniques for transurethral bladder tumor resection
(Turk J Urol 2010; 36: 108-111)
The effect of gender on oncological outcomes in patients who have undergone radical cystectomy due to bladder cancer
(Turk J Urol 2012; 38: 126-131)
DOI: 10.5152/tud.2012.028
Urodynamic evaluation of patients with studer orthotopic urinary diversion and the impact of body mass index on micturition parameters
(Turk J Urol 2011; 37: 20-24)
The feasibility of radical cystectomy in elderly patients
(Turk J Urol 2014; 40: 9-14)
DOI: 10.5152/tud.2014.09735
Muscle-invasive bladder and urethral cancer recurrence after surgical management of upper tract urothelial carcinoma: A review of 305 patients
(Turk J Urol 2018; 44: 213-220)
DOI: 10.5152/tud.2018.19677
Assessment of the quality of life and sexual functions of patients followed-up for non-muscle invasive bladder cancer: preliminary results of the prospective-descriptive study
(Turk J Urol 2018; 44: 393-398)
DOI: 10.5152/tud.2018.30040
Bladder-related quality of life in people with neurological disorders: reliability and validity of the Turkish version of the King’s Health Questionnaire in people with spinal cord injury
(Turk J Urol 2018; 44: 411-417)
DOI: 10.5152/tud.2018.45556
Genital organ involvement in female patients with bladder cancer: evaluation of radical cystectomy specimens
(Turk J Urol 2009; 35: 269-273)
The value of the NMP22 test for superficial bladder cancer diagnosis and follow-up
(Turk J Urol 2013; 39: 137-142)
DOI: 10.5152/tud.2013.029
Ureterocutaneostomy: for whom and when?
(Turk J Urol 2013; 39: 143-146)
DOI: 10.5152/tud.2013.030
Robotic radical cystectomy for the management of bladder cancer: Analysis of operative and pathological outcomes of eighteen patient
(Turk J Urol 2018; 44: 311-315)
DOI: 10.5152/tud.2018.19577
The association between variant urothelial histologies, pathological stage and disease specific survival in patients with bladder cancer
(Turk J Urol 2018; 44: 24-30)
DOI: 10.5152/tud.2017.48107
Predictive role of neutrophil-to-lymphocyte ratio on upstaging of organ- confined invasive urothelial bladder cancer to non-organ- confined disease
(Turk J Urol 2018; 44: 119-124)
DOI: 10.5152/tud.2017.46038
Detection of CYP1A1 and GSTP1 gene polymorphisms in bladder cancer patients in a Turkish population using a polymerase chain reaction-restriction fragment length polymorphism method
(Turk J Urol 2018; 44: 125-131)
DOI: 10.5152/tud.2018.23571
Safety and efficacy of bipolar energy for transurethral resection of bladder tumours: a prospective quasi-randomized study
(Turk J Urol 2017; 43: 141-146)
DOI: 10.5152/tud.2017.33396
Paraoxonase and arylesterase activity in bladder cancer
(Turk J Urol 2017; 43: 147-151)
DOI: 10.5152/tud.2017.89411
Applicability of the EORTC risk tables to predict outcomes in non-muscle-invasive bladder cancer in Turkish patients
(Turk J Urol 2017; 43: 48-54)
DOI: 10.5152/tud.2016.77603
Assessment of bladder wall thickness in women with overactive bladder
(Turk J Urol 2016; 42: 97-100)
DOI: 10.5152/tud.2016.95871
Maintenance treatment with gemcitabine have a promising activity on metastatic bladder cancer survival
(Turk J Urol 2017; 43: 273-278)
DOI: 10.5152/tud.2017.24478
Comparison of translabial ultrasonographic and urodynamic data of female patients with urinary incontinence: Importance of translabial ultrasonography in the diagnosis of incontinence
(Turk J Urol 2018; 44: 490-497)
DOI: 10.5152/tud.2018.81236
Prognostic significance of tumor budding in muscle invasive urothelial carcinomas of the bladder
(Turk J Urol ; : -)
DOI: 10.5152/tud.2018.58269
The attitudes of Urologists and Gynecologists about overactive bladder and treatment of it in Turkey: A questionnaire survey
(Turk J Urol 2017; 43: 68-74)
DOI: 10.5152/tud.2016.93467
The effectiveness of biofeedback therapy in children with monosymptomatic enuresis resistant to desmopressin treatment
(Turk J Urol 2016; 42: 278-284)
DOI: 10.5152/tud.2016.39114
Distribution of interstitial cells of Cajal in the bladders of fetal rats with retinoic acid induced myelomeningocele
(Turk J Urol 2016; 42: 285-289)
DOI: 10.5152/tud.2016.98474
Intravesical silver nitrate for refractory hemorrhagic cystitis
(Turk J Urol 2016; 42: 197-201)
DOI: 10.5152/tud.2016.38445
Relationship between bladder wall thickness and duration of symptoms, uroflowmetry parameters, and international prostate symptom score in patients with lower urinary tract symptoms
(Turk J Urol 2009; 35: 361-365)
Effectiveness of spinal anesthesia combined with obturator nerve blockade in preventing adductor muscle contraction during transurethral resection of bladder tumor
(Turk J Urol 2017; 43: 507-511)
DOI: 10.5152/tud.2017.96992
Our experience with ureterocystoplasty in bilateral functional kidneys
(Turk J Urol ; : -)
DOI: 10.5152/tud.2018.42223
Muscle-invasive bladder and urethral cancer recurrence after surgical management of upper tract urothelial carcinoma: A review of 305 patients
(Turk J Urol ; : -)
DOI: 10.5152/tud.2018.19677
Laparoscopy
Laparoscopic radical cystectomy: Uludag University experience
(Turk J Urol 2009; 35: 224-229)
Female Urology
CUT-OFF VALUES OF PRESSURE-FLOW STUDY FOR THE DIAGNOSIS OF BLADDER OUTLET OBSTRUCTION IN WOMEN
(Turk J Urol 2005; 31: 405-410)
Urooncology
CHARACTERISTICS OF TRANSITIONAL CELL CARCINOMA OF THE BLADDER IN YOUNG ADULTS
(Turk J Urol 2003; 29: 305-308)
STUDER ILEAL NEOBLADDER WITH RADICAL CYSTECTOMY
(Turk J Urol 2003; 29: 386-392)
MANAGEMENT OF EARLY URINARY LEAKAGE AFTER RADICAL CYSTECTOMY
(Turk J Urol 2005; 31: 31-35)
NON-TRANSITIONAL CELL CARCINOMA OF THE BLADDER
(Turk J Urol 2005; 31: 469-473)
THE RATE OF INCIDENTAL PROSTATE CANCER IN PATIENTS UNDERGOING RADICAL CYSTOPROSTATECTOMY FOR BLADDER CANCER
(Turk J Urol 2005; 31: 490-494)
EVALUATION OF SERUM LEVELS OF IMMUNOGLOBULINS (IgA, IgE, IgG, IgM), COMPLEMENTS (C3, C4) AND C-REACTIVE PROTEIN IN BLADDER CANCER: A CONTROLLED PROSPECTIVE CLINICAL TRIAL
(Turk J Urol 2005; 31: 495-502)
LONG-TERM FOLLOW-UP RESULTS OF OUR 10-YEAR ILEAL LOOP SERIES AND COMPARISON OF URETEROILEAL ANASTOMOSIS TECHNIQUES (BRICKER AND WALLACE)
(Turk J Urol 2005; 31: 318-323)
BLADDER WASHING CYTOLOGY: USABILITY DURING FOLLOW-UP AFTER INTRAVESICAL MITOMYCIN C FOR NONINVASIVE UROTHELIAL CANCER
(Turk J Urol 2005; 31: 335-341)
BLADDER WASHING CYTOLOGY: USABILITY DURING FOLLOW-UP AFTER INTRAVESICAL MITOMYCIN C FOR NONINVASIVE UROTHELIAL CANCER
(Turk J Urol 2005; 31: 335-341)
ASSESSMENT OF SERUM CA 19-9 LEVELS AS A TUMOR MARKER IN PATIENTS WITH BLADDER TUMOR
(Turk J Urol 2005; 31: 342-348)
THE EFFECT OF SINGLE DOSE IMMEDIATE MITOMYCINE-C INSTILLATION OVER RECURRENCE IN LOW RISK SUPERFICIAL BLADDER TUMORS: SHORT TERM FOLLOW UP
(Turk J Urol 2001; 27: 407-410)
How does the time interval between transurethral resection and cystectomy affect the oncological outcome after cystectomy in bladder cancer patients?
(Turk J Urol 2009; 35: 77-81)
MANAGEMENT OF BCG-REFRACTORY SUPERFICIAL BLADDER CANCER
(Turk J Urol 2001; 27: 465-468)
THE PROGNOSTIC VALUE OF THE DEPTH OF INVASION IN STAGE pT1 BLADDER CANCER
(Turk J Urol 2002; 28: 16-19)
Experimental
INHIBITION OF THE ISOLATED GUINEA-PIG URINARY BLADDER CONTRACTIONS BY SILDENAFIL (VIAGRA®): IN VITRO STUDY
(Turk J Urol 2005; 31: 12-16)
Other
THE ROLE OF THE OVEREXPRESSION OF p53 AND Ki-67 IN THE UROTHELIAL CELL BLADDER CANCERS DURING FOLLOW UP
(Turk J Urol 2002; 28: 25-32)
EVALUATION OF THE VALUE OF BTA stat TEST IN PRIMARY DIAGNOSIS OF BLADDER CANCER
(Turk J Urol 2002; 28: 33-37)
THE CORRELATION BETWEEN SERUM ANTI-p53 ANTIBODIES AND THE OVEREXPRESSION OF TUMOUR p53 PROTEIN IN PATIENTS WITH BLADDER TUMOR AND ITS CLINICAL IMPORTANCE
(Turk J Urol 2002; 28: 150-156)
THE EFFECT OF FUNCTIONAL BLADDER CAPACITY ON THE TREATMENT OF PRIMARY MONOSYMPTOMATIC ENURESIS NOCTURNA WITH DESMOPRESSIN
(Turk J Urol 2002; 28: 157-160)
USING OF NMP 22 ONLY OR TOGETHER WITH THE CYTOLOGY IN THE DIAGNOSIS AND FOLLOW-UP OF BLADDER TUMORS
(Turk J Urol 2003; 29: 138-145)
NUCLEAR MATRIX PROTEIN 22 (NMP22) IN THE BLADDER TUMOR COMPARISON WITH THE FINDINGS OF CYSTOSCOPY, STAGE AND GRADE OF THE TUMOR
(Turk J Urol 2003; 29: 277-284)
THE BODY IMAGE SCALE IN PATIENTS WITH ILEAL CONDUIT AND ILEAL NEOBLADDER: COMPARISON OF THE SURGICAL TECHNIQUES FROM THE PATIENTS POINT OF VIEW; A PRELIMINARY REPORT
(Turk J Urol 2001; 27: 428-432)
UTILITY OF URINARY NUCLEAR MATRIX PROTEIN 22 (NMP22) IN THE DIAGNOSIS OF TRANSITIONAL CELL CARCINOMA OF THE BLADDER
(Turk J Urol 2001; 27: 279-284)
OUR CASES WITH TRANSITIONAL CELL CARCINOMA OF THE BLADDER: THE DISTRIBUTION OF AGE, GENDER AND TUMOR GRADE
(Turk J Urol 2001; 27: 295-299)
Invited Review
Approaching the optimal transurethral resection of a bladder tumor
(Turk J Urol 2014; 40: 73-77)
DOI: 10.5152/tud.2014.94715
Imaging assessments of lower urinary tract dysfunctions: Future steps
(Turk J Urol 2014; 40: 78-81)
DOI: 10.5152/tud.2014.43650
What is new in non-muscle-invasive bladder cancer in 2016?
(Turk J Urol 2017; 43: 9-13)
DOI: 10.5152/tud.2017.60376
Alternative therapies in patients with non-muscle invasive bladder cancer
(Turk J Urol 2017; 43: 414-424)
DOI: 10.5152/tud.2017.64624
Systematic Review
Diagnosis and treatment of inguinal hernia of the bladder: a systematic review of the past 10 years
(Turk J Urol 2018; 44: 384-388)
DOI: 10.5152/tud.2018.46417
Key Words
Authors
All
Survey
AVES | Copyright © 2018 Turkish Association of Urology | Latest Update: 08.10.2018